64 related articles for article (PubMed ID: 9920182)
1. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
2. Modulation of spinal motor networks by astrocyte-derived adenosine is dependent on D
Acton D; Broadhead MJ; Miles GB
J Neurophysiol; 2018 Sep; 120(3):998-1009. PubMed ID: 29790837
[TBL] [Abstract][Full Text] [Related]
3. Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.
Arias-Montaño JA; Floran B; Garcia M; Aceves J; Young JM
Br J Pharmacol; 2001 May; 133(1):165-71. PubMed ID: 11325806
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors in human platelets.
Ricci A; Bronzetti E; Mannino F; Mignini F; Morosetti C; Tayebati SK; Amenta F
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):376-82. PubMed ID: 11330330
[TBL] [Abstract][Full Text] [Related]
5. c-Fos expression by dopaminergic receptor activation in rat hippocampal neurons.
Kang DK; Kim KO; Lee SH; Lee YS; Son H
Mol Cells; 2000 Oct; 10(5):546-51. PubMed ID: 11101146
[TBL] [Abstract][Full Text] [Related]
6. Initial characterization of a transgenic mouse with overexpression of the human D
Abella LMR; Jacob H; Hesse C; Hofmann B; Schneider S; Schindler L; Keller M; Buchwalow IB; Jin C; Panula P; Dhein S; Klimas J; Hadova K; Gergs U; Neumann J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4939-4959. PubMed ID: 38177456
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of adult rat retinal ganglion cells by D1-type dopamine receptor activation.
Hayashida Y; Rodríguez CV; Ogata G; Partida GJ; Oi H; Stradleigh TW; Lee SC; Colado AF; Ishida AT
J Neurosci; 2009 Nov; 29(47):15001-16. PubMed ID: 19940196
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the human D1 and D2 dopamine receptor signaling complexes.
Zhuang Y; Xu P; Mao C; Wang L; Krumm B; Zhou XE; Huang S; Liu H; Cheng X; Huang XP; Shen DD; Xu T; Liu YF; Wang Y; Guo J; Jiang Y; Jiang H; Melcher K; Roth BL; Zhang Y; Zhang C; Xu HE
Cell; 2021 Feb; 184(4):931-942.e18. PubMed ID: 33571431
[TBL] [Abstract][Full Text] [Related]
9. Opioid regulation of Pavlovian overshadowing in fear conditioning.
Zelikowsky M; Fanselow MS
Behav Neurosci; 2010 Aug; 124(4):510-9. PubMed ID: 20695650
[TBL] [Abstract][Full Text] [Related]
10. Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice.
Dumartin B; Jaber M; Gonon F; Caron MG; Giros B; Bloch B
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1879-84. PubMed ID: 10677550
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the dopaminergic system in the reward-related behavior of pregabalin.
Althobaiti YS; Almutairi FM; Alshehri FS; Altowairqi E; Marghalani AM; Alghorabi AA; Alsanie WF; Gaber A; Alsaab HO; Almalki AH; Hakami AY; Alkhalifa T; Almalki AD; Hardy AMG; Shah ZA
Sci Rep; 2021 May; 11(1):10577. PubMed ID: 34011976
[TBL] [Abstract][Full Text] [Related]
12. Activation of Multiple G Protein Pathways to Characterize the Five Dopamine Receptor Subtypes Using Bioluminescence Technology.
Mönnich D; Humphrys LJ; Höring C; Hoare BL; Forster L; Pockes S
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):834-854. PubMed ID: 38481695
[TBL] [Abstract][Full Text] [Related]
13. Dopamine and noradrenaline activate spinal astrocyte endfeet via D1-like receptors.
Montalant A; Kiehn O; Perrier JF
Eur J Neurosci; 2024 Mar; 59(6):1278-1295. PubMed ID: 38052454
[TBL] [Abstract][Full Text] [Related]
14. Specificity of striatal dopamine D
Goto S
Front Hum Neurosci; 2023; 17():1178616. PubMed ID: 37180553
[No Abstract] [Full Text] [Related]
15. Activation of Dopamine Receptor D1 and Downstream Cellular Functions by Polydopamine.
Sun X; Wu C; Tian X; Wang P; Guo J; Shao Z; Wei Q
ACS Biomater Sci Eng; 2024 Jan; 10(1):420-428. PubMed ID: 38142403
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor and seizures.
Vavers E; Zvejniece L; Dambrova M
Pharmacol Res; 2023 May; 191():106771. PubMed ID: 37068533
[TBL] [Abstract][Full Text] [Related]
17. A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods.
Bueschbell B; Barreto CAV; Preto AJ; Schiedel AC; Moreira IS
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934701
[No Abstract] [Full Text] [Related]
18. Activation of Dopamine D1-D2 Receptor Complex Attenuates Cocaine Reward and Reinstatement of Cocaine-Seeking through Inhibition of DARPP-32, ERK, and ΔFosB.
Hasbi A; Perreault ML; Shen MYF; Fan T; Nguyen T; Alijaniaram M; Banasikowski TJ; Grace AA; O'Dowd BF; Fletcher PJ; George SR
Front Pharmacol; 2017; 8():924. PubMed ID: 29354053
[TBL] [Abstract][Full Text] [Related]
19. Evidence against dopamine D1/D2 receptor heteromers.
Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
[TBL] [Abstract][Full Text] [Related]
20. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.
Hasbi A; Perreault ML; Shen MY; Zhang L; To R; Fan T; Nguyen T; Ji X; O'Dowd BF; George SR
FASEB J; 2014 Nov; 28(11):4806-20. PubMed ID: 25063849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
